New Horizon Health Closed US$ 20m in Series D Round

New Horizon Health Closed US$ 20m in Series D Round

 

New Horizon Health is a leading Chinese molecular diagnostic company focusing on early cancer detection. VMS led its series C financing and participated in its series D financing. On product side, the Company has launched at-home cancer screening products for intestinal cancer, cervical cancer, gastric cancer and lung cancer.

Please browse the link below for more detail:
https://www.chinamoneynetwork.com/2020/04/21/chinese-cancer-screening-firm-new-horizon-health-raises-20m-in-series-d-round